Oxford BioDynamics Plc (AIM:OBD)
London · Delayed Price · Currency is GBP · Price in GBX 0.1160
+0.0010 (0.87%)
Sep 25, 2026, 1:51 PM GMT
Oxford BioDynamics Market Cap
Oxford BioDynamics has a market cap or net worth of 15.46 million as of September 24, 2026. Its market cap has increased by 66.23% in one year.
Market Cap
15.46M
Enterprise Value
17.22M
Revenue
1.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
ChartMarket Cap Chart
Since December 6, 2016, Oxford BioDynamics's market cap has decreased from 136.90M to 15.46M, a decrease of -88.71%. That is a compound annual growth rate of -19.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 15.46M | 67.55% |
| Dec 31, 2025 | 9.23M | 92.61% |
| Dec 31, 2024 | 4.79M | -91.54% |
| Dec 29, 2023 | 56.64M | 125.13% |
| Dec 30, 2022 | 25.16M | -34.45% |
| Dec 31, 2021 | 38.38M | -50.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arecor Therapeutics | 33.04M |
| Hemogenyx Pharmaceuticals | 31.96M |
| ImmuPharma | 22.89M |
| IXICO | 16.42M |
| SkinBioTherapeutics | 16.20M |
| Palatin Technologies | 14.56M |
| Fusion Antibodies | 14.02M |
| Aptamer Group | 11.23M |